DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	WT1; HOXA6; HOXA11; HOXA13; HOXC12; HOXD11; HOXD12; IRX4; ISL2; DMRTA2; FOXA2; DLX2; FOXD3; EGR4; EMX2; FOXC2; ZIC5; FOXL2; SP8; ZIC2; DLX6; FOXI3; EN1; EN2; TCF15; NR2E1; FOXD1; VAX1; DLX5;	GO:0006357~regulation of transcription by RNA polymerase II	29	747	3.88219544846051	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT75; KRT16; KRTAP2-3; CDH3; CASP14; KRT76; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE2A; LCE2C; LCE2D; KRT27; KRTAP4-1;	GO:0031424~keratinization	20	181	11.0497237569061	0	0	0	0	0	0	0
down	MCIDAS; BMPR1B; HOXC11; CHP2; LMX1B; GLI2; HOXD8; LIF; WT1; EN2; GAL; PAX7; PAX3; HOXD10; HOXC13; TLX1; HOXD13; GATA4; NKX2-1; HMGA2; GBX2; PRRX1; FOXL2; ISL1; EGR4; EN1; TCF15; FOXF2; SIX1; ALX1; FOXD1; MAFA; FOXC2; GATA5; ALX4; SIX2; HOXC10; LHX3; SIX4; FOXD3; FOXA2; NR2E1; LHX1; NKX1-2; LHX5; DLX5; HOXC9; SOX1; DLX2; LHX2; HOXD9; DLX6;	GO:0045944~positive regulation of transcription by RNA polymerase II	52	1138	4.56942003514938	0	0	0	0	0	0	0
down	GLI2; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00011076141564281	0.00268303069446832	0.120840704466309	0.125824968170235	0.108324664498671	0.120840704466309	0.0204257096801006
down	HOXD9; HOXD10; HOXA11; FOXL2; DEFB126;	GO:0007338~single fertilization	5	61	8.19672131147541	0.00011100567133803	0.00268303069446832	0.120996181758461	0.126102442640011	0.108452540897263	0.120996181758461	0.0204257096801006
up	UGT1A9; UGT1A1; CYP2C18; UGT1A3; UGT1A7; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	9	25	36	0.00012627457327429	0.037187861829281	0.296618972621328	0.297502894634248	0.296492698048053	0.296618972621328	0.310226662756523
down	HOXD9; HOXA11; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	4	33	12.1212121212121	0.00013815152341256	0.0032695860540974	0.150447008996285	0.156940130596675	0.127375704586386	0.150447008996285	0.024891111254444
down	WT1; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00017912879902315	0.00415286358551638	0.194892133337191	0.203490315690303	0.150802395715709	0.194892133337191	0.0316154362727588
down	WT1; LHX1; SIX1; FOXC2;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.00020713674998651	0.0047061469596936	0.225157647235341	0.23530734798468	0.166021606351557	0.225157647235341	0.0358275407392005
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00025607643827052	0.0630952601449254	0.601267477059193	0.603316088565357	0.600499247744381	0.601267477059193	0.526350024649787
up	HP; HPR; JCHAIN; IGKV1-5; IGKV3-20; IGLV1-47; IGLV2-14; IGLV3-1; IGHV3-23; IGKC; IGHA2; APOA1; IGKV3-11; IGKV4-1; IGLC2; IGLC3; FOLR2; FCGR2B; IGLV3-21; COLEC12; CLEC9A; FCGR1B; STAB1; CD207;	GO:0006898~receptor-mediated endocytosis	24	160	15	0.00026780670689696	0.0630952601449254	0.628542341087181	0.630952601449254	0.628006727673387	0.628542341087181	0.526350024649787
down	HOXA11; LHX1; FOXL2;	GO:0060065~uterus development	3	15	20	0.00026890097957377	0.00598963750580009	0.292026463817116	0.305471512795805	0.198986724884591	0.292026463817116	0.045598657158396
down	MMP1; MMP3; MMP10; MMP13;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.00035277204638606	0.00728634626717395	0.38169935418972	0.400749044694567	0.232597844738014	0.38169935418972	0.0554704028503378
down	KITLG; GBX2; ISL1; ALX1;	GO:0001755~neural crest cell migration	4	44	9.09090909090909	0.00038269499137366	0.00776324125358009	0.413693285674934	0.434741510200485	0.241863234548157	0.413693285674934	0.0591009683001891
down	LHX2; DLX2; NR2E1;	GO:0021772~olfactory bulb development	3	18	16.6666666666667	0.00043139494157173	0.00803384678074582	0.465906536897478	0.490064653625495	0.255817200352041	0.464180957131191	0.0611610677046103
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.00043139494157173	0.00803384678074582	0.465906536897478	0.490064653625495	0.255817200352041	0.464180957131191	0.0611610677046103
down	BMPR1B; ISL1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.00043139494157173	0.00803384678074582	0.465906536897478	0.490064653625495	0.255817200352041	0.464180957131191	0.0611610677046103
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00043139494157173	0.00803384678074582	0.465906536897478	0.490064653625495	0.255817200352041	0.464180957131191	0.0611610677046103
down	LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.00043139494157173	0.00803384678074582	0.465906536897478	0.490064653625495	0.255817200352041	0.464180957131191	0.0611610677046103
down	DLX2; DLX5; DLX6;	GO:0009790~embryo development	3	19	15.7894736842105	0.00049688147170989	0.00830445725068221	0.53414758208814	0.564457351862444	0.273487055608681	0.531397540903689	0.0632212047379704
down	BMPR1B; HOXA11; GDF6;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00049688147170989	0.00830445725068221	0.53414758208814	0.564457351862444	0.273487055608681	0.531397540903689	0.0632212047379704
down	LHX1; EN1; CDK5R2; GBX2;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.00052067768034769	0.00857231659239099	0.556083762611335	0.591489844874978	0.279987716315039	0.556083762611335	0.0652603976402829
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.00056840792679957	0.00909452682879319	0.606491257895146	0.645711404844317	0.292730082301781	0.605922849968346	0.069235944659823
down	PRRX1; SIX1; SIX2;	GO:0042474~middle ear morphogenesis	3	20	15	0.00056840792679957	0.00909452682879319	0.606491257895146	0.645711404844317	0.292730082301781	0.605922849968346	0.069235944659823
down	NR2E1; SIX1; SIX4; SIX2;	GO:0048856~anatomical structure development	4	50	8	0.00060147698221346	0.00934684155270754	0.640572986057342	0.683277851794498	0.301362613596002	0.640572986057342	0.0711567975629652
down	WT1; KITLG; HOXA11; GATA4; SIX4;	GO:0008584~male gonad development	5	90	5.55555555555556	0.0006082319298829	0.00934684155270754	0.647158773395414	0.690951472346983	0.303321829774009	0.647158773395414	0.0711567975629652
down	EN2; ISL1; EN1; SIX1; NTRK2; SIX4;	GO:0043524~negative regulation of neuron apoptotic process	6	138	4.34782608695652	0.00060886115748271	0.00934684155270754	0.64721941040412	0.691666274900358	0.303321829774009	0.64721941040412	0.0711567975629652
up	IGKV1-5; IGKV3-20; IGLV1-47; IGLV2-14; IGLV3-1; IGHV3-23; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGKV3-11; IGKV4-1; IGLC2; IGLC3; IGLV3-21; TRDC; TRBC2; TRBC1; IGHA2;	GO:0006958~complement activation, classical pathway	23	161	14.2857142857143	0.00065103050819592	0.126290742602452	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; ABRA; SYNPO2L; GPR55; LPAR4; GPR174; GPR17; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	9	33	27.2727272727273	0.00069685044729705	0.126290742602452	1	1	0.999999999948627	0.999999999948627	1
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.0008213877522375	0.0118113479309089	0.869028241867276	0.933096486541801	0.350074954860287	0.869028241867276	0.089918898156776
up	APOA1; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.00095413229231167	0.160566834334736	1	1	0.999999999948627	0.999999999948627	1
down	FOXG1; ISL1; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.00107740129923495	0.0145705699515583	1	1	0.393251474220756	0.958678017879669	0.110924646638492
down	MMP1; MMP3; LIF; ALOX15; IL13RA2; IL31; IFNL1; IL20;	GO:0019221~cytokine-mediated signaling pathway	8	278	2.87769784172662	0.00110943325688229	0.0148272491743327	1	1	0.398286539220741	0.958678017879669	0.11287872614124
down	ZIC2; NKX2-1; FOXG1; DLX2; VAX1; DMBX1; EMX2;	GO:0007420~brain development	7	217	3.2258064516129	0.00119386147244382	0.0157700771243742	1	1	0.410864546537979	0.958678017879669	0.12005640399097
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00124650907225787	0.195785024949303	1	1	0.999999999948627	0.999999999948627	1
down	SOX1; NKX2-1; CDK5R2; NTRK2; VAX1;	GO:0001764~neuron migration	5	109	4.58715596330275	0.00138086421931949	0.0170791738163891	1	1	0.437578861915646	0.958678017879669	0.130022458061617
down	HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	3	28	10.7142857142857	0.00138317252738362	0.0170791738163891	1	1	0.437578861915646	0.958678017879669	0.130022458061617
down	NKX2-1; DLX2; CDK5R2; LHX5;	GO:0021766~hippocampus development	4	64	6.25	0.00143254490079303	0.0174986129817299	1	1	0.444448257298475	0.958678017879669	0.13321561669278
down	DSCAM; PCDHB8; PCDHA11; PCDHAC2; CDH26; CDH3;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	6	165	3.63636363636364	0.00148005163413711	0.0178335297108651	1	1	0.45141574841182	0.958678017879669	0.135765312412037
down	PAX3; LHX1; LHX3; LAMB3; LAMA3;	GO:0009887~animal organ morphogenesis	5	111	4.5045045045045	0.00149136031913044	0.0178335297108651	1	1	0.453101728782774	0.958678017879669	0.135765312412037
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.00151825647058035	0.0179660349018675	1	1	0.456995197644685	0.958678017879669	0.136774064405856
down	MMP13; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	3	30	10	0.00166132825172838	0.0191821066814677	1	1	0.476801208246044	0.958678017879669	0.146031926856512
down	LIF; ISL1; IFNL1; IL20;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	4	69	5.79710144927536	0.0018620739933185	0.020145867203903	1	1	0.504622052189314	0.958678017879669	0.153368962796128
down	HOXD8; HOXC8; TCF15;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.00214011493394961	0.0223599804858839	1	1	0.535139348560353	0.958678017879669	0.17022483969304
down	BMPR1B; DLX5; GATA5;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.00214011493394961	0.0223599804858839	1	1	0.535139348560353	0.958678017879669	0.17022483969304
down	BMPR1B; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	3	36	8.33333333333333	0.00269651453717201	0.0261815428566445	1	1	0.574357596417639	0.958678017879669	0.199318104883964
up	JCHAIN; IGKV1-5; IGKV3-20; IGLV1-47; IGLV2-14; IGLV3-1; IGHV3-23; IGKC; IGHA2; IGKV3-11; IGKV4-1; CEACAM5; CD48; IGLC2; IGLC3; PSG1; SELE; CEACAM3; IGLV3-21; ANGPT1; FCAMR; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	24	193	12.4352331606218	0.00272968114141658	0.357284931620971	1	1	0.999999999948627	0.999999999948627	1
down	HOXC13; LHX2; ALX4;	GO:0001942~hair follicle development	3	37	8.10810810810811	0.002899909321598	0.0276831679776078	1	1	0.588681592284395	0.958678017879669	0.210749863317581
down	GLI2; HMGA2; SIX2;	GO:0002062~chondrocyte differentiation	3	37	8.10810810810811	0.002899909321598	0.0276831679776078	1	1	0.588681592284395	0.958678017879669	0.210749863317581
down	GLI2; WT1; ISL1; IRX4; FOXC2; POPDC3;	GO:0007507~heart development	6	190	3.15789473684211	0.00292962108380901	0.0277337462600586	1	1	0.59069762024123	0.958678017879669	0.211134911955149
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0029644283422785	0.367589114442534	1	1	0.999999999948627	0.999999999948627	1
down	CCL24; GATA4; HMGA2; ISL1; NR2E1;	GO:0045766~positive regulation of angiogenesis	5	131	3.81679389312977	0.00298293822844276	0.0280051060124874	1	1	0.593778123286854	0.958678017879669	0.213200753219433
down	WT1; LAMB3; LAMA3;	GO:0009888~tissue development	3	39	7.69230769230769	0.00333440703068355	0.0305474708617461	1	1	0.618290502222542	0.958678017879669	0.232555584462667
up	CD5L; RAET1L; CD300LG; IDO2; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	8	35	22.8571428571429	0.00351882821899108	0.414517964197149	1	1	0.999999999948627	0.999999999948627	1
down	MMP1; MELTF; MMP13; NOTUM; AMTN; PAPPA2;	GO:0044267~cellular protein metabolic process	6	200	3	0.00373760614899954	0.032914113064058	1	1	0.64660586377692	0.958678017879669	0.250572652489791
down	WT1; VAX1; FOXC2;	GO:0043010~camera-type eye development	3	42	7.14285714285714	0.00405731959014854	0.0354547311877596	1	1	0.668464277856528	0.958678017879669	0.269914186043515
down	PTHLH; ALOX15; MMP13;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.00458808370443275	0.0381138731365605	1	1	0.692841458457336	0.958678017879669	0.290158032510261
down	FGF19; ALOX15; GATA4; CCL24; CCL26; NTRK2;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	6	209	2.87081339712919	0.00459647941875774	0.0381138731365605	1	1	0.694068392232418	0.958678017879669	0.290158032510261
down	TCF15; FOXC2; HES7;	GO:0001756~somitogenesis	3	46	6.52173913043478	0.00515892480888558	0.0401406752253015	1	1	0.710501242418845	0.958678017879669	0.305587923464918
down	KCNQ1; SIX1; LHX3;	GO:0048839~inner ear development	3	46	6.52173913043478	0.00515892480888558	0.0401406752253015	1	1	0.710501242418845	0.958678017879669	0.305587923464918
down	HTRA3; RBPMS2; SOST;	GO:0030514~negative regulation of BMP signaling pathway	3	47	6.38297872340426	0.00545962790770416	0.0421914102255233	1	1	0.718818146594317	0.958678017879669	0.321200013863926
up	APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	4	9	44.4444444444444	0.00583481097247951	0.597687593528771	1	1	0.999999999948627	0.999999999948627	1
down	SLC26A4; ANO4; ANO1; SLC26A10;	GO:1902476~chloride transmembrane transport	4	97	4.12371134020619	0.00598119687147669	0.0444094094509642	1	1	0.733263295951715	0.958678017879669	0.338085474154391
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00617823162178932	0.606496404205652	1	1	0.999999999948627	0.999999999948627	1
down	CCL24; ALOX15; CCL26;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.00676649680316288	0.0489601297349875	1	1	0.75512209339201	0.958678017879669	0.372729763371225
down	SLC26A4; SIX1; SIX4;	GO:0032880~regulation of protein localization	3	51	5.88235294117647	0.00676649680316288	0.0489601297349875	1	1	0.75512209339201	0.958678017879669	0.372729763371225
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.00683835043310665	0.644446144815971	1	1	0.999999999948627	0.999999999948627	1
down	KRT16; SPRR2B; SPRR2G;	GO:0030216~keratinocyte differentiation	3	53	5.66037735849057	0.0074835561272566	0.0524772824726142	1	1	0.774993727428642	0.958678017879669	0.399505581056594
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.00778708244455273	0.705629470744855	1	1	0.999999999948627	0.999999999948627	1
down	TRABD2B; MMP1; MMP3;	GO:0031334~positive regulation of protein-containing complex assembly	3	54	5.55555555555556	0.00785826551424407	0.0547668075103145	1	1	0.785826551424407	0.958678017879669	0.41693556194418
down	NR2E1; GATA5; GATA4;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.00824385661625215	0.0571037872930637	1	1	0.794535479154653	0.958678017879669	0.434726812215418
up	CCL21; TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00842173507197641	0.708628851056301	1	1	0.999999999948627	0.999999999948627	1
up	CCL21; AIF1; CCL19; RARRES2; P2RY12;	GO:0050921~positive regulation of chemotaxis	5	17	29.4117647058824	0.00842173507197641	0.708628851056301	1	1	0.999999999948627	0.999999999948627	1
down	BMPR1B; LHX2; NR2E1;	GO:0060041~retina development in camera-type eye	3	56	5.35714285714286	0.00864039678195239	0.0594878226927146	1	1	0.803556900721572	0.958678017879669	0.452876293337922
down	LIF; EPHA8; ADRA1B; NTRK2;	GO:0043410~positive regulation of MAPK cascade	4	109	3.6697247706422	0.00882853622158053	0.0596977211173541	1	1	0.808540438040523	0.958678017879669	0.454474234163883
down	GATA4; POSTN; SOST;	GO:0009612~response to mechanical stimulus	3	57	5.26315789473684	0.00904795016544058	0.06046159639965	1	1	0.814315514889652	0.958678017879669	0.460289558893544
down	GLI2; DLX2; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	3	57	5.26315789473684	0.00904795016544058	0.06046159639965	1	1	0.814315514889652	0.958678017879669	0.460289558893544
up	LTF; RARRES2; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.00944906288091762	0.742066404914731	1	1	0.999999999948627	0.999999999948627	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00944906288091762	0.742066404914731	1	1	0.999999999948627	0.999999999948627	1
down	PAX7; PRRX1; DLX2;	GO:0051216~cartilage development	3	58	5.17241379310345	0.00946657777922422	0.0621455103458311	1	1	0.823592266792507	0.958678017879669	0.473109068361654
down	WT1; NTRK2; HAS2;	GO:0001570~vasculogenesis	3	60	5	0.0103372843606311	0.0636124158012639	1	1	0.842800626093088	0.958678017879669	0.484276508608462
up	CCL2; FOLR2; CCR2; CCL14; CCL18; CCL21; CCL19; CCL11;	GO:0002548~monocyte chemotaxis	8	44	18.1818181818182	0.0113786639344802	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	F13A1; IVL; FLG; SPRR1A; TGM3; TGM7;	GO:0018149~peptide cross-linking	6	27	22.2222222222222	0.0123249281202943	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; APOC3; LPL; CETP; GPIHBP1; APOA4;	GO:0070328~triglyceride homeostasis	6	27	22.2222222222222	0.0123249281202943	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	IGLV1-50; TRBV20-1; IGLV5-52; TRAV13-1; TRBV28; LILRA1; JCHAIN; HLA-DQA2; TRGC2; CD3D; HLA-DQB2; CD1A; CD3G; TRGC1; CD8B; CD1E; CTLA4; HLA-DMB; CD1B; CD1C; CD79B; SLAMF1; TRAT1; SKAP1; CLEC10A; ZNF683; LILRB2; LILRB1; FCAMR; FCGR1B; SIGLEC10; CD209; CD84; SIT1;	GO:0002250~adaptive immune response	34	347	9.79827089337176	0.0130409834134968	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0135503397852423	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0135503397852423	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0135503397852423	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	POSTN; HAS2; CCL26; CCL24;	GO:0071356~cellular response to tumor necrosis factor	4	125	3.2	0.0138256940708517	0.0636124158012639	1	1	0.905067959535861	0.958678017879669	0.484276508608462
down	KCNQ2; KCNQ1; SLC9A3; KCNF1;	GO:0071805~potassium ion transmembrane transport	4	125	3.2	0.0138256940708517	0.0636124158012639	1	1	0.905067959535861	0.958678017879669	0.484276508608462
down	MELTF; ROS1; PAPPA2;	GO:0001558~regulation of cell growth	3	69	4.34782608695652	0.0148168418949691	0.0657497359089255	1	1	0.919072879606048	0.958678017879669	0.500547764879419
up	JCHAIN; IGKV3-20; IGHA2; MCAM;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.0160500258943382	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CCL2; AQP1; CCR2; MUC17;	GO:0019725~cellular homeostasis	4	13	30.7692307692308	0.0160500258943382	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	NTRK2; ROS1; EPHA8;	GO:0033674~positive regulation of kinase activity	3	73	4.10958904109589	0.0171073746355914	0.0735639209402164	1	1	0.944252077943378	0.958678017879669	0.560036564304937
up	CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.0172696114980107	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CCL21; CD5L; IL18RAP; LY86; CCL2; FOLR2; SELE; CD40LG; FCGR2B; CNR2; CXCR3; CSRP3; AIF1; MS4A2; FUT7; NAIP; TRIL; PLD4; CD180; CCL19; RARRES2; STAB1; CCL11; PTGDR; ACKR1; CXCL13; CCL14; GPR33; IL36RN; CCR5; CCL18; IL36B; FPR3; CCR2; GGT5; IL2RA;	GO:0006954~inflammatory response	36	381	9.44881889763779	0.0173985884945095	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	SPI1; LY6D; FLT3;	GO:0030098~lymphocyte differentiation	3	7	42.8571428571429	0.0185092397913196	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	3	7	42.8571428571429	0.0185092397913196	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0185092397913196	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0185092397913196	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CCL21; LILRB1; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.0185092397913196	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	ALOX15; FOXC2; SOST;	GO:0001503~ossification	3	76	3.94736842105263	0.0189476693765258	0.0735639209402164	1	1	0.954042774752614	0.958678017879669	0.560036564304937
up	CTAGE4; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	4	14	28.5714285714286	0.0196807045142822	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0196807045142822	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	WT1; CDH3; NKX2-1; HMGA2; NTRK2; FOXD1; GATA5;	GO:0010628~positive regulation of gene expression	7	374	1.8716577540107	0.0200792349130704	0.0735639209402164	1	1	0.958678017879669	0.958678017879669	0.560036564304937
up	SELE; AVPR1A; ADCYAP1R1; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	6	31	19.3548387096774	0.0211444846771954	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	JCHAIN; IGKV3-20; IGHA2; LTF; H2BFS; RNASE6;	GO:0019731~antibacterial humoral response	6	31	19.3548387096774	0.0211444846771954	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	SLC26A4; PAX3; KCNQ1; SIX1;	GO:0007605~sensory perception of sound	4	143	2.7972027972028	0.0212508768986457	0.0736005980392119	1	1	0.958678017879669	0.958678017879669	0.560315784284617
down	GLI2; NKX2-1; LHX3;	GO:0030324~lung development	3	80	3.75	0.021565255138002	0.0744624007196665	1	1	0.958678017879669	0.958678017879669	0.566876622887318
down	LIPN; LIPM; PNLIPRP3;	GO:0016042~lipid catabolic process	3	81	3.7037037037037	0.022248954462425	0.0756730906266911	1	1	0.958678017879669	0.958678017879669	0.576093513549246
down	GLI2; FOXG1; GDF6;	GO:0045666~positive regulation of neuron differentiation	3	81	3.7037037037037	0.022248954462425	0.0756730906266911	1	1	0.958678017879669	0.958678017879669	0.576093513549246
down	HAS2; CCL26; CCL24;	GO:0071347~cellular response to interleukin-1	3	81	3.7037037037037	0.022248954462425	0.0756730906266911	1	1	0.958678017879669	0.958678017879669	0.576093513549246
up	HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; CCL19; CD209; CD80;	GO:0042102~positive regulation of T cell proliferation	9	61	14.7540983606557	0.0229052537558549	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	CHP2; ALOX15; LCE1D;	GO:0071277~cellular response to calcium ion	3	82	3.65853658536585	0.0229443781506616	0.0775737723557151	1	1	0.958678017879669	0.958678017879669	0.590563259747587
up	FABP12; APOC3; LPL; FABP1; FABP2;	GO:0019433~triglyceride catabolic process	5	23	21.7391304347826	0.0233910757830879	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CFTR; AQP1; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.0243385440847166	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.0243385440847166	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0243385440847166	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	BMPR1B; DLX5; GDF6;	GO:0030509~BMP signaling pathway	3	85	3.52941176470588	0.0251009662210313	0.0775737723557151	1	1	0.958678017879669	0.958678017879669	0.590563259747587
down	PTHLH; LIF; WT1; AZGP1; SSTR5; IFNL1; SCIN;	GO:0008285~negative regulation of cell population proliferation	7	396	1.76767676767677	0.0262124739463168	0.0775737723557151	1	1	0.958678017879669	0.958678017879669	0.590563259747587
down	DSCAM; C1QL1; NKX2-1;	GO:0007626~locomotory behavior	3	87	3.44827586206897	0.0265972262114871	0.0775737723557151	1	1	0.958678017879669	0.958678017879669	0.590563259747587
up	CCL18; CCL2; CCL14; CCL21; CCL19; CCL11;	GO:0048247~lymphocyte chemotaxis	6	33	18.1818181818182	0.0268403366747008	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	IL2RA; SCGB1A1; CTLA4; LILRB2; LILRB1; FOXJ1; CD80;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.0280094874900807	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.0283536171403458	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	ADH1A; CYP2C9; UGT1A1; CYP2C19; UGT1A7;	GO:0017144~drug metabolic process	5	25	20	0.0307596729025125	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	MT1A; MT1G; GLRA1; MT1H; MT1M;	GO:0071294~cellular response to zinc ion	5	25	20	0.0307596729025125	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.0310387451792808	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0310387451792808	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; APOC3; APOA4; CETP;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0334160328362114	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; APOC3; APOA4; CETP;	GO:0043691~reverse cholesterol transport	4	17	23.5294117647059	0.0334160328362114	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
down	SLC26A4; SLC9A3; SLC5A12;	GO:0006811~ion transport	3	96	3.125	0.0339068679026862	0.0852447901283313	1	1	0.958678017879669	0.958678017879669	0.648962137664785
up	ADRA2A; GHR; AIF1; ROBO2; AVPR2; RAMP3; AVPR1A;	GO:0032870~cellular response to hormone stimulus	7	46	15.2173913043478	0.0371008636940033	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0385999254413387	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA1; APOC3; APOA4;	GO:0034378~chylomicron assembly	3	10	30	0.0385999254413387	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	MT1A; MT1G; MT1H; MT1M;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.0389703212282377	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	CCL2; CD40LG; FASLG; ECSCR;	GO:2000353~positive regulation of endothelial cell apoptotic process	4	19	21.0526315789474	0.0450184483467113	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	APOA4; GPIHBP1; APOA1;	GO:0051006~positive regulation of lipoprotein lipase activity	3	11	27.2727272727273	0.0470034280768312	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	MT1G; AQP1; MT1A; MT1M; MT1H;	GO:0071280~cellular response to copper ion	5	29	17.2413793103448	0.0494577732123599	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
up	LPAR4; GPR65; GPR17; P2RY10; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	6	39	15.3846153846154	0.0496811734539471	0.75475346072199	1	1	0.999999999948627	0.999999999948627	1
